红凤菜新鲜茎叶中总黄酮提取物的LC-MS分析

红凤菜（Gynura bicolor DC.）为菊科（Compositae）菊三七属（Gynura Cass.）植物,别名血皮菜、观音菜、观音苋、紫背天葵等,主要分布于中国南方各地,全草均可入药[1];也可作为蔬菜食用,在国内多个地区均有栽培和销售。目前已知红凤菜含有黄酮类、酚性酸类、萜类、甾醇类、脂肪酸类、生物碱类及花青素类等[2-7]成分。由于黄酮类成分多具有保护心血管、抗肿瘤、抗糖尿病、抗氧化、抗炎和抗病毒等作用[8],因此对红凤菜中黄酮类成分的研究具有深度开发价值。     

Modulation of synaptic plasticity by brain estrogen in the hippocampus

The hippocampus is a center for learning and memory as well as a target of Alzheimer's disease in aged humans. Synaptic modulation by estrogen is essential to understand the molecular mechanisms of estrogen replacement therapy. Because the local synthesis of estrogen occurs in the hippocampus of both sexes, in addition to the estrogen supply from the gonads, its functions are attracting much attention.     

杭白菊花水提物的UHPLC-ESI-Orbitrap质谱联用分析

为阐明杭白菊花水提物的药效物质基础,采用超高压液相-高分辨质谱联用技术对杭白菊(Chrysanthemum morifolium)花水提物的化学成分进行分析和鉴定。结果表明,从杭白菊花水提物中鉴定出376种化学成分,其中相对含量大于0.1%的成分有152种,相对含量较高的有绞股蓝皂苷XXⅦ、含羞草碱-O-β-葡萄糖苷、甲基-β-葡萄糖苷、D-1-O-甲基粘质肌醇、L(+)-甲基肌醇、过氧化苯甲酰、甲基-β-半乳糖苷、甲基-α-果糖苷、芒柄醇、松醇、(E)-2-己烯-α-阿拉伯糖-(1→2)-β-葡萄糖苷、米瑟毒苷等。杭白菊花水提物主要以黄酮类和生物碱类成分为主,分别有40和53种,相对含量分别为22.68%和26.57%,是杭白菊花发挥功效的主要物质基础。     

偏斜淫羊藿化学成分研究

采用70%乙醇超声波辅助提取偏斜淫羊藿（Epimedium truncatum H.R.Liang）叶片中的类黄酮化学成分,利用LC-MS联用技术鉴定其化合物组成,利用HPLC方法测定其主要活性成分的含量并与药典规定药材箭叶淫羊藿（Epimedium sagittatum）主要活性成分的含量进行比较。结果从偏斜淫羊藿叶片中鉴定出6个化合物：朝藿定B、朝藿定C、淫羊藿苷、3,5,7-三羟基4’-甲氧基-8-异戊烯基黄酮-3-O-α-L-吡喃鼠李糖基（1→2）-α-L-吡喃鼠李糖苷、槲皮素-3-O-鼠李糖甙、山奈苷。该6个化合物均为首次在该植物中发现。偏斜淫羊藿富含朝藿定C,其含量显著高于箭叶淫羊藿主要活性成分的总含量。结果表明LC-MS可以简单、快速地对淫羊藿化学成分进行定性和定量分析,偏斜淫羊藿富含朝藿定C,具有潜在的药用价值。     

rhIL-12二硫键、N-糖基化位点及C端氨基酸序列分析

重组人白细胞介素12（rhIL-12）是一种已经用于治疗肿瘤,寄生虫、病毒性感染及造血障碍等疾病研究的异二聚体糖蛋白。结构确证是质量控制的重要内容,此研究对CHO细胞表达的rhIL-12二硫键配对方式、N-糖基化位点以及C端氨基酸序列进行了分析,使用Trypsin、Chymotrypsin和Glu-C三种酶分别对rhIL-12进行非还原酶解,尽可能地在其所有半胱氨酸残基之间断裂而形成二硫键相连的肽段,然后使用LC-MS/MS对酶解后的肽段样品进行分析,确定了rhIL-12样品中存在和理论配对方式相符的7对二硫键。将rhIL-12二硫键还原后并烷基化修饰保护,分别采用Trypsin,Chymotrypsin和GluC进行酶解,并用LC-MS/MS对酶解后肽段进行了质谱肽图及C端氨基酸序列分析,确定了rhIL-12 p35亚基C端氨基酸序列的8个氨基酸、p40亚基C端氨基酸序列的15个氨基酸。对rhIL-12样品还原及烷基化后用Trypsin变性酶解,所得肽段在H₂O及H₂¹⁸O水中分别用PNGase F糖苷酶处理酶切产物。并通过二级质谱分析脱糖后糖肽段分子量变化,从而确定了rhIL-12的3个N糖基化修饰位点,分别为p35亚基的71位和85位以及p40亚基的200位。通过建立酶解结合二级质谱鉴定的方法,证明了新药rhIL-12的二硫键位点、C端氨基酸序列和糖基化位点与理论一致。     

A multifaceted approach to identify non-specific enzyme inhibition: Application to Mycobacterium tuberculosis shikimate kinase

Single dose high-throughput screening (HTS) followed by dose-response evaluations is a common strategy for the identification of initial hits for further development. Early identification and exclusion of false positives is a cost-saving and essential step in early drug discovery. One of the mechanisms of false positive compounds is the formation of aggregates in assays. This study evaluates the mechanism(s) of inhibition of a set of 14 compounds identified previously as actives in Mycobacterium tuberculosis (Mt) cell culture screening and in vitro actives in Mt shikimate kinase (MtSK) assay. Aggregation of hit compounds was characterized using multiple experimental methods, LC-MS, ¹HNMR, dynamic light scattering (DLS), transmission electron microscopy (TEM), and visual inspection after centrifugation for orthogonal confirmation. Our results suggest that the investigated compounds containing oxadiazole-amide and aminobenzothiazole moieties are false positive hits and non-specific inhibitors of MtSK through aggregate formation.     

云锦杜鹃苯丙氨酸解氨酶基因的克隆及功能分析

苯丙氨酸解氨酶(phenylalaninammo-nialyase,PAL)是植物香气化合物中苯甲酸甲酯合成途径的关键酶.为探究云锦杜鹃Rhododendron fortunei RhPAL基因的功能,利用RT-PCR和cDNA末端快速扩增技术(rapid amplification of cDNA ends,RACE...     

基于UPLC-MS/MS定量检测法优化灵芝三萜热回流提取工艺的研究

基于超高效液相-三重四级杆质谱联用（UPLC-MS/MS）定量检测法优化出一种灵芝三萜热回流提取的工艺。通过本实验建立的灵芝三萜UPLC-MS/MS精确方法检测不同来源的7个栽培品种灵芝子实体中19个三萜化合物的含量,筛选出三萜含量较高的sd-2灵芝子实体作为提取原料,以三萜含量和提取物得率为指标,通过单因素和响应面实验对灵芝三萜的热回流工艺进行优化,获得的最佳条件为：乙醇浓度75%、提取时间2.5h、液料比14:1、提取次数2次。对获得的最佳提取工艺进行中试实验,灵芝子实体乙醇提取物的得率为6.10%,三萜含量为11.8591mg/g。研究结果可为灵芝三萜的工业大规模提取提供理论依据,为灵芝高附加值产品的开发利用提供技术支撑。     

Characterization of Glycoproteoforms of Integrins α2 and β1 in Megakaryocytes in the Occurrence of JAK2V617F Mutation-Induced Primary Myelofibrosis

Primary myelofibrosis (PMF) is a neoplasm prone to leukemic transformation, for which limited treatment is available. Among individuals diagnosed with PMF, the most prevalent mutation is the JAK2V617F somatic point mutation that activates the Janus kinase 2 (JAK2) enzyme. Our earlier reports on hyperactivity of β1 integrin and enhanced adhesion activity of the α2β1 complex in JAK2V617F megakaryocytes (MKs) led us to examine the new hypothesis that this mutation leads to posttranslational modification via changes in glycosylation. Samples were derived from immunoprecipitation of MKs obtained from Vav1-hJAK2^V617F and WT mice. Immunoprecipitated fractions were separated by SDS-PAGE and analyzed using LC-MS/MS techniques in a bottom-up glycoproteomics workflow. In the immunoprecipitate, glycopeptiforms corresponding to 11 out of the 12 potential N-glycosylation sites of integrin β1 and to all nine potential glycosylation sites of integrin α2 were observed. Glycopeptiforms were compared across WT and JAK2V617F phenotypes for both integrins. The overall trend observed is that JAK2V617F mutation in PMF MKs leads to changes in β1 glycosylation; in most cases, it results in an increase in the integrated area of glycopeptiforms. We also observed that in mutated MKs, changes in integrin α2 glycosylation were more substantial than those observed for integrin β1 glycosylation, a finding that suggests that altered integrin α2 glycosylation may also affect activation. Additionally, the identification of proteins associated to the cytoskeleton that were co-immunoprecipitated with integrins α2 and β1 demonstrated the potential of the methodology employed in this study to provide some insight, at the peptide level, into the consequences of integrin activation in MKs. The extensive and detailed glycosylation patterns we uncovered provide a basis for future functional studies of each site in control cells as compared to JAK2V617F-mutated cells. Data are available via ProteomeXchange with identifier PXD030550.     

Discovery and characterization of hydroxylysine in recombinant monoclonal antibodies

Tryptic peptide mapping analysis of a Chinese hamster ovary (CHO)-expressed, recombinant IgG1 monoclonal antibody revealed a previously unreported +16 Da modification. Through a combination of MSⁿ experiments, and preparation and analysis of known synthetic peptides, the possibility of a sequence variant (Ala to Ser) was ruled out and the presence of hydroxylysine was confirmed. Post-translational hydroxylation of lysine was found in a consensus sequence (XKG) known to be the site of modification in other proteins such as collagen, and was therefore presumed to result from the activity of the CHO homolog of the lysyl hydroxylase complex. Although this consensus sequence was present in several locations in the antibody sequence, only a single site on the heavy-chain Fab was found to be modified.